Navigation Links
Federal DePuy ASR Litigation Schedules July Conference to Discuss Lawsuits over Recalled Hip Replacement

(PRWEB) July 19, 2014

A federal litigation that now includes more than 8,600 DePuy ASR hip lawsuits ( has scheduled a meeting to discuss issues pertaining to claims involving the recalled metal-on-metal hip replacement, Bernstein Liebhard LLP reports.

According to documents updated this week, a status conference in the U.S. District Court, Northern District of Ohio has been scheduled to take place on July 18, 2014 at 9:30 a.m. Parties involved in the litigation will address a Progress Report on the MDL by the leadership, an oral argument on pending motions in several lawsuits over the DePuy ASR Hip Replacement System, and matters related to a DePuy settlement agreement proposed last year, court records indicate. (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation – MDL 2197)

“As our Firm continues to represent numerous individuals in the DePuy ASR recall litigation, we are pleased to see the proceeding moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free and confidential case evaluations to individuals who allegedly suffered chronic pain, premature hip failure, symptoms associated with metallosis and other complications associated with the DePuy ASR recall.

DePuy ASR Litigation
Court documents indicate that cases in the DePuy ASR hip litigation are continuing to move forward in the Northern District of Ohio. According to a Case List updated on July 15th, a total of 8,656 lawsuits have now been filed in the federal litigation by plaintiffs who were allegedly injured by the metal-on-metal hip replacement. Court records indicate that Plaintiffs in these cases similarly allege that the Johnson & Johnson subsidiary, DePuy Orthopaedics defectively designed a product that, because of its all-metal design, may shred dangerous amounts of toxic metal debris into the blood stream. These individuals were implanted with the ASR metal-on-metal hip replacement prior to its recall in August 2010.

In November 2013, Johnson & Johnson and DePuy proposed an ASR settlement that would resolve some 8,000 claims filed in the wake of the recall. According to court documents, the agreement stipulates that only individuals who underwent an ASR revision surgery prior to August 31, 2013 would be eligible to participate, and receive a base award of $250,000. Other factors, including prior medical history and the number of revision surgeries undergone by each plaintiff, could affect the award amount. DePuy ASR lawsuit plaintiffs who are either not eligible, or wish not to participate in the settlement may pursue individual claims against Johnson & Johnson and DePuy.

Individuals who were allegedly harmed by a DePuy ASR hip implant may be entitled to compensation for medical bills, lost wages, pain and suffering, and more. Learn more about filing a DePuy ASR lawsuit, please visit Bernstein Liebhard LLP’s website. For a free, no obligation case review, please call the Firm directly at 800-511-5092.

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. MCG/VA psychology training program gets federal funding for fifth consecutive time
2. Federal Judge Overseeing Ethicon Vaginal Mesh Lawsuit Denies Summary Judgment on Certain Claims, Bernstein Liebhard LLP Reports
3. Transvaginal Mesh Lawsuit News: Federal Plaintiff Allowed to Pursue Claims Related to Use of Prolene in Ethicon Mesh Products, Bernstein Liebhard LLP Reports
4. Ethicon Vaginal Mesh Lawsuits Move Forward, As Federal Court Schedules Pretrial Conference for Second Bellwether Case, Bernstein Liebhard LLP Reports
5. Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports
6. Federal funding cliff could cause health safety net clinics to shrink by one-quarter
7. GranuFlo Lawsuits News: Missouri Federal Court Returns Multi-Plaintiff Case to State Court, Rottenstein Law Group LLP Reports
8. Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Order in Federal C.R. Bard Litigation
9. Pradaxa Lawsuits Move Forward, as Federal Litigation Schedules January Status Conference, Bernstein Liebhard LLP Reports
10. Fosamax Lawsuits: Bellwether Trials Scheduled in Federal, State Fosamax Femur Fracture Litigations, Bernstein Liebhard LLP Reports
11. Transvaginal Mesh Lawsuit News: Bellwether Trial in Federal C.R. Bard Vaginal Mesh Litigation Postponed, Bernstein Liebhard LLP Reports
Post Your Comments:
(Date:11/27/2015)... ... 2015 , ... The print component of “Supporting Our Caregivers” ... New York, Minneapolis, South Florida, with a circulation of approximately 250,000 copies and ... vast social media strategy and across a network of top news sites and ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... A simply ... Jones, is an interesting show that delves into an array of issues that are ... that could benefit from open dialogue, this show is changing the subjects consumers focus ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... Dr. ... Medical Associates, Inc. and Dr. Tucker Bierbaum with Emergency Medicine at St., ... observed that both STEMI and Sepsis conditions present in similar ways and require time-critical ...
(Date:11/26/2015)... ... November 26, 2015 , ... CognisantMD and Cambridge ... imaging in the Waterloo region. Using the Ocean Platform, family physicians can now ... their electronic medical record (EMR) without the need for redundant patient entry or ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... opinion process, participated in the 61st annual Employee Benefits Conference. The Employee Benefits ... place Sunday, November 8th through Wednesday, November 11th, 2015. The conference was held ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... Nov. 26, 2015  The total global healthcare industry is ... 2015-2016. Latin America has the highest ... (excluding Japan ), is second with growth ... to face increased healthcare expenditure. In 2013-2014, total government funded ... 43.5% in 2008-2009 to 41.2% in 2013-2014. In real terms, ...
(Date:11/25/2015)... , Nov. 25, 2015 AAIPharma Services ... investment of at least $15.8  Million to expand ... Wilmington, NC . The expansion will provide ... meet the growing demands of the pharmaceutical and ... site expansion will provide up to 40,000 square ...
(Date:11/25/2015)... 2015 Kitov Pharma ceuticals ... a biopharmaceutical company focused on the development of therapeutic ... today announced the closing of its previously announced underwritten ... ), each representing 20 ordinary shares of the Company, ... ADSs and warrants were issued in a fixed combination ...
Breaking Medicine Technology: